Evidence map›Paper›PMID 34474108›Full record

ArticleInternational journal of radiation oncology, biology, physics2022

Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy.

Ida Franiak-Pietryga, Sayuri Miyauchi, Sangwoo Shawn Kim, Philip Dominick Sanders, Whitney Sumner, Lin Zhang, A J Mundt, Joseph A Califano, Andrew B Sharabi

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ida Franiak-PietrygaDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Sayuri MiyauchiDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Sangwoo Shawn KimDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Philip Dominick SandersDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Whitney SumnerDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Lin ZhangDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
A J MundtDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California.
Joseph A CalifanoDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California; Department of Surgery, Division of Otolaryngology, University of California, San Diego, California.
Andrew B SharabiDepartment of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, California. Electronic address: sharabi@ucsd.edu.
University of California San Diego · US

Funding

Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck CancersU01DE028227 · NIDCR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI GUTKIND, JORGE SILVIO, RAO, ANJANA · 2018 to 2022
$4.6M
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCCR01DE028563 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHARABI, ANDREW B. · 2019 to 2023
$1.8M
NIDCR NIH HHS R01 DE028563NIDCR NIH HHS U01 DE028227
6 · The paper itself

Abstract

purposeB cells play a key role in outcomes of cancer patients and responses to checkpoint blockade immunotherapies. However, the effect of radiation therapy on B cell populations is poorly understood. Here we characterize the effects of radiation on the development, survival, and phenotype of physiological B-cell subsets. METHODS AND MATERIALS: Naïve and immunized tumor bearing and nontumor bearing mice were treated with large-field or focal stereotactic radiation and distinct B-cell subsets of varying developmental stages were analyzed by flow cytometry and real-time reverse transcription polymerase chain reaction.

resultsWe first report that focal stereotactic radiation is highly superior to large-field radiation at inducing tumor infiltration of B cells, CD8

conclusionsThese data demonstrate that stereotactic radiation is superior to large-field radiation at inducing infiltration of immune cells into tumors and that plasma cells and class switched B cells are highly resistant to radiation therapy. These results represent the most comprehensive analysis of the effects of radiation on B cells to date and identify novel mechanisms by which radiation modulates immune cells within the tumor microenvironment.

Indexed as

CD8-Positive T-LymphocytesPlasma CellsAnimalsB-LymphocytesHumansLymphocyte CountMiceTumor Microenvironment

Identifiers

PMID34474108
PMCPMC8976465
OpenAlexW3198754187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.